Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial.
Saved in:
| Title: | Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial. |
|---|---|
| Authors: | Genovese MC; Division of Immunology and Rheumatology, Stanford University, Stanford, California., Kalunian K; Division of Rheumatology, Allergy, and Immunology, University of California, San Diego, La Jolla., Gottenberg JE; Department of Rheumatology, Strasbourg University Hospital, Strasbourg, France., Mozaffarian N; Gilead Sciences Inc, Foster City, California., Bartok B; Gilead Sciences Inc, Foster City, California., Matzkies F; Gilead Sciences Inc, Foster City, California., Gao J; Gilead Sciences Inc, Foster City, California., Guo Y; Gilead Sciences Inc, Foster City, California., Tasset C; Galapagos NV, Mechelen, Belgium., Sundy JS; Gilead Sciences Inc, Foster City, California., de Vlam K; Department of Rheumatology, Universitair Ziekenhuis Leuven, Leuven, Belgium., Walker D; Northumbria Healthcare, North Shields, United Kingdom., Takeuchi T; Division of Rheumatology, Keio University School of Medicine, Tokyo, Japan. |
| Source: | JAMA [JAMA] 2019 Jul 23; Vol. 322 (4), pp. 315-325. |
| Publication Type: | Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1538-3598 |
|---|---|
| DOI: | 10.1001/jama.2019.9055 |
